Fig. 2From: The efficacy and safety of Nab-paclitaxel plus gemcitabine versus mFOLFIRINOX in the first-line treatment of metastatic pancreatic cancer: a retrospective studyReceiver operating characteristic (ROC) analysis was established to determine the optimal cut-off value of PNIBack to article page